Chronic Spontaneous Urticaria (CSU) Clinical Trials in Montpellier
2 recruitingMontpellier, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals44 enrolled17 locationsNCT06865651
Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639